This Grand Canyon Education Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Enliven Therapeutics, Inc.
FrontView REIT, Inc.
Grand Canyon Education, Inc.
Magnite, Inc.

Enliven Therapeutics, Inc.

ELVN

0.00

FrontView REIT, Inc.

FVR

0.00

Grand Canyon Education, Inc.

LOPE

0.00

Magnite, Inc.

MGNI

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Stifel analyst Dara Azar initiated coverage on Enliven Therapeutics Inc (NASDAQ:ELVN) with a Buy rating and announced a price target of $60. Enliven Therapeutics shares closed at $33.63 on Monday. See how other analysts view this stock.
  • Truist Securities analyst Jasper Bibb initiated coverage on Grand Canyon Education Inc (NASDAQ:LOPE) with a Buy rating and announced a price target of $200. Grand Canyon Education shares closed at $148.59 on Monday. See how other analysts view this stock.
  • Raymond James analyst RJ Milligan initiated coverage on FrontView REIT Inc (NYSE:FVR) with a Strong Buy rating and announced a price target of $22. FrontView shares closed at $18.99 on Monday. See how other analysts view this stock.
  • BTIG analyst Tyler DiMatteo initiated coverage on Magnite Inc (NASDAQ:MGNI) with a Buy rating and announced a price target of $20. Magnite shares closed at $14.63 on Monday. See how other analysts view this stock.

Considering buying LOPE stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.